Exhibit 3.
Characteristics and COVID-19 vaccine metrics from 218 PWID, Syringe Services Program Clients, Baltimore City Health Department, April 2021-June 2022.
| Characteristics | N | % |
|---|---|---|
| Age (Mean, SD) | 52 | 13 |
| Gender | ||
| Female | 62 | 28% |
| Male | 156 | 72% |
| Race | ||
| Black | 176 | 81% |
| White | 21 | 15% |
| Other | 5 | 2% |
| Not Specified | 4 | 2% |
| Ethnicity | ||
| Hispanic or Latino | 5 | 2.5% |
| Non-Hispanic or Latino | 208 | 95% |
| Not Specified | 5 | 2.5% |
| Dose 1 COVID-19 vaccine (n=218) | ||
| Viral vector | 77 | 35% |
| mRNA | 141 | 65% |
| Dose 2 COVID-19 vaccine (n=133) | ||
| Viral vector | 4 | 3% |
| mRNA | 128 | 96.5% |
| Unspecified | 1 | 0.5% |
| Booster 1 COVID-19 vaccine (n=66) | ||
| Viral vector | 1 | 1.5% |
| mRNA | 65 | 98.5% |
| Booster 2 COVID-19 vaccine (n=9) | ||
| mRNA | 9 | 100% |
Notes: All values are number and percent except for Age, which is mean and standard deviation.
Source: Author’s analysis of abstracted data from the electronic health record where COVID-19 vaccine data was entered Please list sources here.